Search Results 1561-1570 of 19450 for Hemoglobin
Participation eligibility · Hemoglobin ≥ 8 g/dL; · Absolute neutrophil count ≥ 1000/μL; · Platelet count ≥ 75,000/μL (≥ 30,000/μL if bone marrow plasma cells ...
In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...
Hemoglobin ≥ 9.0 g/dL;; Phosphorus ≤ ULN. Creatinine clearance (calculated* or measured value**): ≥ 40 mL/min. * For a calculated creatinine clearance (Ccr) ...
People with A-fib often have problems with blood clots forming that can lead to strokes. To prevent the clots, health care providers generally prescribe these ...
Hemoglobin < 8 g/dL. Enrollment in another interventional clinical study while participating in this study. For Substudy 3 only: Total SES-CD > 4 and/or ...
It includes four parameters: glycemic control (hemoglobin A1C less than 7%), insulin use, number of T2DM medications and duration of T2DM. Because the ...
Hemoglobin ≥ 8 g/dL (obtained ≤ 14 days prior to randomization). Untransfused platelet count ≥ 75,000 cells/mm^3 (obtained ≤ 14 days prior to ...
Clinically significant abnormal hematology (white blood cell count less than 3 or greater than 10 x 10^9/L, hemoglobin less than 9.5 or greater than 15.5 g ...
Hemoglobin ≥ 9 g/dL;; Total bilirubin ≤ 1.5 × upper limit of normal (ULN) (isolated bilirubin > 1.5 x ULN is acceptable if bilirubin is fractionated and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.